NT5E and head and neck squamous cell carcinoma: Second, for the role of CD73 in the prediction of immunotherapy efficacy of HNSCC patients, we just used the bioinformatics prediction algorithm TIDE to evaluate the potential response, and the actual validation cohort is another cancer type, namely a cohort of metastatic urothelial carcinoma.